IRIS BINCOVICH

IRIS BINCOVICH

Chief Executive Officer

20-year Healthcare and Biotech industry veteran. Led hundreds of successful global transactions in the OTC, cosmetics and dermatology sectors.​​

The InnoCan Pharma management team impresses with its passion, dedication, and unwavering commitment, which speaks to its exceptional nature. It is a unique combination of experts in the fields of pharmaceuticals, biotechnology, and finance. Led by CEO Iris Binkovich, who has over 20 years of experience in global markets, the company strives to unlock the full potential of cannabinoids’ therapeutic properties in combination with smart delivery formulas.

The situation is similar in the online gaming industry. Backed by experienced management teams, platforms such as those offering a 10 euro gratis gokken zonder storting guarantee an entertaining but safe gaming environment for their users. These platforms strive to provide the best user experience, just as InnoCan Pharma’s goal is to deliver exceptionally effective therapeutic solutions. Both sectors prove that with the right leadership and customer-focused strategies, even a no deposit operation can be highly profitable.

RONI KAMHI

RONI KAMHI

Chief Operating Officer // Chief Executive Officer - B.I. Sky Global LTD

Over 20 years of experience spanning global retail, e-commerce, healthcare, and AI technology, Roni has established himself as a pioneering entrepreneur and strategic business leader. His expertise encompasses advanced wellness and beauty solutions, digital transformation, analytics, and data-driven decision-making. As a serial founder, he has successfully scaled multiple startups from inception to nine-figure revenues. Roni’s proven track record includes developing and implementing international business strategies that have effectively penetrated new markets and driven global expansion.

NELSON HALPERN

NELSON HALPERN

FCPA, FCA, TEP CFO

Extensive experience with public and private companies. Member of the Chartered Professional Accountants of Alberta.

EYAL KALO, PhD

EYAL KALO, PhD

Vice President, R&D

Former Scientific Team Leader at Beckman Coulter Molecular Diagnostics. Development of FDA approved assay to detect HIV. PhD in cancer research, Weizmann Institute.

EYAL FLOM

EYAL FLOM

General Counsel

Served as the Israeli Pharmaceutical Association legal counsel since April 1995. He has also served as a director of several startup companies in the field of technology and biotech. Obtained his LLM from Tel Aviv University and MBA from Derby university.

Accessibility Toolbar